Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Applying a specific inhibitor lightens skin and hair color.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Finasteride improves prostate cancer detection in PSA test.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Finasteride reduces prostate size and PSA levels in young patients.

Urinary PSA could be an early marker for enlarged prostate.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Finasteride 5 mg effectively reduces urinary symptoms and PSA levels in men with enlarged prostates, with few sexual side effects.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.